Not Found
Digital Seminar

MDMA and Psychotherapy

For millennia, cultures around the world have embraced mind-altering substances to catalyze healing. Western psychotherapy has generally resisted the healing potential of such substances, but the FDA has lately approved clinical trials using MDMA—also known as Ecstasy, or Molly—to treat PTSD. Psychotherapists have a major role to play in these treatments, by helping clients process the healing shifts in consciousness that can occur on the drug.


Product Details
Average Rating:
Not yet rated
Michael Mithoefer, MD
2 Hours 59 Minutes
Audio and Video
Mar 25, 2018
Product Code:
Media Type:
Digital Seminar
Never expires.


Continuing Professional Development Certificates - PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This online program is worth 3 hours CPD.


Michael Mithoefer, MD's Profile

Michael Mithoefer, MD Related seminars and products

Michael Mithoefer, MD, clinical assistant professor of psychiatry at the Medical University of South Carolina. In 2009, he completed & published the first FDA approved clinical trial of MDMA assisted psychotherapy for treatment-resistant PTSD, followed by completion of a Phase II trial. He is overseeing a multisite Phase III study of MDMA-assisted psychotherapy in 13 sites around the US (including the Trauma Research Foundation), and another MDMA-assisted psychotherapy multisite study in Europe and Israel.


Speaker Disclosures:

Financial: Michael Mithoefer receives a salary and grants from MAPS Public Benefit Corp and is a clinical assistant professor at the Medical University of South Carolina.

Non-financial: Michael Mithoefer is a member of the non-profit MAPS.


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.


  1. Explore specifics of the role therapists play in the healing process of MDMA-assisted psychotherapy, including balancing a non-directive approach with interventions based on the therapist’s training and intuition.
  2. Explore what typically happens in the eight-hour therapy sessions that accompany the administering of MDMA.
  3. Explore the history of MDMA and how its pharmacologic profile makes it effective against treatment resistant PTSD.
  4. Identify the research processes used to determine the efficacy of MDMA and analyze the clinical impact on patients and quality of life after MDMA Assisted Psychotherapy in order to improve clinical outcomes with Post Traumatic Stress Disorder.


History of MDMA
  • MDMA as Psychedelic
  • MDMA Pharmacology
  • MDMA Therapy Use in the 1970’s and 1980’s
Clinical Trials & Results
  • Study Design
  • Neuropsychology Measures
  • Study with Veterans, Firefighters, & Police Officers
  • Drug Treatment Development Protocol with Couples
  • MDMA Therapy with Therapists
  • MDMA Side Effects
Therapeutic Approach / MDMA in Psychotherapy
  • Video Case Study
  • Manual for MDMA Assisted Psychotherapy
  • Why Does MDMA Work?
  • Imaging
  • MDMA Assisted Psychotherapy Agreements
The Future of MDMA Assisted Psychotherapy
  • Further Research
  • Expanded Access Clinics
  • Training Program

Target Audience

  • Psychologists
  • Physicians
  • Addiction Counselors
  • Counselors
  • Social Workers
  • Marriage & Family Therapists
  • Nurses
  • Other Behavioral Health Professionals


Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or email

Please wait ...

Back to Top